Femoxetine

From Self-sufficiency
Jump to: navigation, search
Femoxetine
File:Femoxetine.png
Systematic (IUPAC) name
(3R,4S)-3-[(4-methoxyphenoxy)methyl]-1-methyl-4-phenyl-piperidine
Clinical data
Routes of
administration
Oral
Legal status
Legal status
  • Uncontrolled
Pharmacokinetic data
Biological half-life 7-27 hours
Identifiers
CAS Number 59859-58-4
ATC code none
PubChem CID 3012003
ChemSpider 2280941
Chemical data
Formula C20H25NO2
Molar mass 311.42 g/mol[[Script error: No such module "String".]]
Script error: No such module "collapsible list".
Script error: No such module "TemplatePar".Expression error: Unexpected < operator.

Femoxetine (Malexil, FG-4963) is a drug related to paroxetine that was being developed as an antidepressant by the pharmaceutical company Ferrosan in 1974. It functions as a selective serotonin reuptake inhibitor (SSRI). Development was halted for unknown reasons, perhaps to focus attention on paroxetine instead.

Dr. Jorgen Buus-Lassen of Ferrosan invented both femoxetine and paroxetine in the 1970s.[1]

References

Cite error: Invalid <references> tag; parameter "group" is allowed only.

Use <references />, or <references group="..." />


  1. http://www.nicox.com/update/lassen.html